Subsequently, exemplary structural crystallographic analyses for CLL subsets 2 and 4 have revealed homotypic interactions between BCR heterodimers as the mechanistic basis for this BCR activation (20). Here, BCR is linked to B-cell chronic lymphocytic leukemia.